REPARE THERAPEUTICS INC's ticker is RPTX and the CUSIP is 760273102. A total of 75 filers reported holding REPARE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $320,651 | -5.0% | 26,544 | -16.8% | 0.00% | – |
| Q2 2023 | $337,406 | +29.2% | 31,891 | +20.1% | 0.00% | – |
| Q1 2023 | $261,192 | +66872.3% | 26,544 | 0.0% | 0.00% | – |
| Q4 2022 | $390 | -99.8% | 26,544 | +24.0% | 0.00% | – |
| Q3 2022 | $259,000 | -13.4% | 21,402 | 0.0% | 0.00% | – |
| Q2 2022 | $299,000 | -1.6% | 21,402 | 0.0% | 0.00% | – |
| Q1 2022 | $304,000 | -32.6% | 21,402 | 0.0% | 0.00% | – |
| Q4 2021 | $451,000 | -19.6% | 21,402 | 0.0% | 0.00% | – |
| Q3 2021 | $561,000 | -15.9% | 21,402 | 0.0% | 0.00% | – |
| Q2 2021 | $667,000 | +1.7% | 21,402 | 0.0% | 0.00% | – |
| Q1 2021 | $656,000 | -10.6% | 21,402 | 0.0% | 0.00% | – |
| Q4 2020 | $734,000 | +11.6% | 21,402 | 0.0% | 0.00% | – |
| Q3 2020 | $658,000 | -0.8% | 21,402 | 0.0% | 0.00% | – |
| Q2 2020 | $663,000 | – | 21,402 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 2,532,150 | $86,853,000 | 24.47% |
| MPM ASSET MANAGEMENT LLC | 3,003,772 | $103,029,000 | 14.58% |
| MPM BioImpact LLC | 4,776,674 | $163,840,000 | 14.15% |
| BVF INC/IL | 2,972,191 | $101,946,000 | 4.01% |
| Logos Global Management LP | 676,894 | $23,217,000 | 1.99% |
| Redmile Group, LLC | 2,647,696 | $90,816,000 | 1.10% |
| Orbimed Advisors | 3,426,325 | $117,523,000 | 1.03% |
| CLOUGH CAPITAL PARTNERS L P | 280,979 | $9,638,000 | 0.68% |
| SPHERA FUNDS MANAGEMENT LTD. | 224,300 | $7,693,000 | 0.68% |
| Artal Group S.A. | 570,000 | $19,551,000 | 0.42% |